Purchase Order 75N91019P00293

This is a $114,966.00 firm-fixed-price purchase order awarded by the Department of Health and Human Services (HHS), National Institutes of Health (NIH), National Cancer Institute (NCI) to Gene Square Bio-Technology LTD, a for-profit limited liability company based in China. The contract is for genetic studies of myeloid and lymphoid malignancy in China in support of NCI's Division of Cancer Epidemiology and Genetics. The work will involve scanning 2,129 DNA samples from the NCI's AsiaLymph study...

This federal contract was awarded by a U.S. government agency to Reprocell U.S.A., Inc., a for-profit organization that specializes in providing biological materials and related services to support biomedical research. The contract is for DNA sample analysis, with a firm fixed price of $73,647.00 and a completion date of April 30, 2008. The work is being performed in Laurel, Maryland and was awarded on May 1, 2007 without any set-aside designation. Reprocell U.S.A., Inc. has primarily worked...

<p>This federal contract award with ID HHSN261201600713P was issued by the National Cancer Institute, a civilian agency, to Gene Square Bio-Technology LTD., a for-profit limited liability company, to provide support and scanning of DNA samples from the ASIALYMPH study. The contract has a firm fixed price of $139,808.00 and an ultimate completion date of September 15, 2017. The contract was awarded on September 16, 2016 and was not set aside for any specific business type.</p>

This is a delivery order contract awarded under the NCI Cancer Genome Atlas Program Tissue Purchase indefinite delivery/indefinite quantity (IDIQ) contract. The contract was awarded by the National Cancer Institute (NCI), a component of the U.S. Department of Health and Human Services, for the recovery of tissue samples and data from various cancer types for the Cancer Genome Atlas (TCGA) program. This work is funded through the American Recovery and Reinvestment Act (ARRA). The contract was...

The National Cancer Institute (NCI) awarded a firm fixed price delivery order to the Fred Hutchinson Cancer Research Center, a non-profit organization, to support the NCI SEER Patterns of Care (POC)/Quality of Care Study for diagnosis year 2019 for urinary bladder cancer and kidney cancer. This $95,989 delivery order was issued against the Surveillance Epidemiology and End Results (SEER) indefinite delivery contract. The study will take place in Seattle, WA and has a completion date of April...

The National Heart, Lung, and Blood Institute of the National Institutes of Health within the Department of Health and Human Services awarded a $391,500 purchase order to The Broad Institute, Inc. for whole genome sequencing services related to sickle cell disease. Per the pre-solicitation notice, the Broad Institute will sequence the DNA of 5,000 sickle cell patients to identify genetic factors influencing clinical outcomes. Performance will occur in Cambridge, Massachusetts over a 24-month...

The National Cancer Institute (NCI) awarded a $2,220,788.57 firm fixed price delivery order contract to the Research Institute at Nationwide Children's Hospital, a non-profit organization, to provide biospecimen core resource services in support of the Cancer Models Development Centers (CMDC) program. This delivery order contract is part of a larger Indefinite Delivery Contract between the Research Institute and the Department of Health and Human Services' Health Resources and Services...

The U.S. Department of Health and Human Services (HHS), National Institutes of Health (NIH), National Cancer Institute (NCI), Division of Cancer Epidemiology and Genetics (DCEG), Infections and Immunoepidemiology Branch (IIB) awarded a $397,800.00 firm fixed-price purchase order contract to Deutsches Krebsforschungszentrum (DKFZ), a non-profit organization and foundation based in Germany. The contract, which does not have a set-aside designation, is for the testing of various elements related to...

This is a delivery order contract awarded to the University of Kentucky Research Foundation (the Research Foundation) by the National Cancer Institute (NCI), part of the National Institutes of Health (NIH). The $211,456 firm fixed-price award is for the NCI's Surveillance, Epidemiology, and End Results (SEER) Patterns of Care (POC)/Quality of Care Study for diagnosis year 2019, focused on urinary bladder cancer and kidney cancer. The contract has an ultimate completion date of April 4, 2022...

This is a firm fixed-price delivery order contract awarded by the National Cancer Institute (NCI) to The Henry M. Jackson Foundation for the Advancement of Military Medicine, Inc. (HJF) in the amount of $201,998.50. The contract is part of the NCI Cancer Genome Atlas Program Tissue Purchase, an indefinite delivery contract. The contract is for the recovery and provision of tissue samples and data from various types of cancer to support the Cancer Genome Atlas (TCGA) program, which is part of the...